Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Powassan Virus Can Cause Permanent Brain Damage After Just 15 Minutes of Tick Attachment as 2026's Record Tick Season Raises Risk Across the U.S.

Powassan virus is North America's most lethal tick-borne pathogen — killing 10% of neurological cases and leaving 50% of survivors with permanent deficits. It can transmit in as little as 15 minutes. With 2026 shaping up as one of the worst tick seasons ever, here is the complete warning for…

Medical Daily

‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.

Euronews

Chikungunya Outbreaks Are Now Active in Three Different Countries and Territories Simultaneously — and Summer Travelers Are at Risk from the Caribbean to the Indian Ocean

Active CDC travel notices cover chikungunya outbreaks in Suriname (Feb 2026), Mayotte (March 2026), and French Guiana (June 4, 2026). The FDA-approved Ixchiq vaccine is available but underused. Here is everything summer travelers to the Caribbean and Indian Ocean need to know.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Meningococcal Cases Reach Second-Highest Level in Over a Decade as Drug-Resistant Strain Disproportionately Hits Black Americans

CDC surveillance data (updated June 2026): 463 meningococcal disease cases in 2025 — the second-highest annual count since 2014. The dominant ST-1466 strain is drug resistant and disproportionately kills Black adults ages 30–60 and people with HIV. Here is the full picture.

Medical Daily

Yellow Fever Colombia 2026 Outbreak: 76 Dead Since 2024 with Case Fatality Rate Exceeding 70 Percent as CDC Issues Active Level 2 Travel Notice

Yellow fever in Colombia has killed 76 people since 2024, with case fatality rates exceeding 40–70% in some periods. 35 cases and 18 deaths in 2026 alone. Venezuela also reports an active outbreak. CDC Level 2 travel notice covers Colombia and South America. Here is what travelers need to know.

Medical Daily

Hepatitis A Outbreak in Canada Leaves 4 Dead, 142 Hospitalized; CDC Issues Travel Notice as Many Americans Traveling to Canada Remain Unvaccinated.

The CDC issued a hepatitis A travel notice for Manitoba, Canada on June 4, 2026. The outbreak has grown to 658 cases, 142 hospitalizations, and 4 deaths since April 2025. Winnipeg restaurant exposures have been identified. Here is what U.S. travelers need to know before visiting Canada.

Medical Daily

The First Lyme Disease Vaccine in 24 Years Just Passed Its Pivotal Phase 3 Trial with 74 Percent Efficacy — and It Is for Children Too

Pfizer and Valneva announced Phase 3 VALOR trial results for Lyme disease vaccine PF-07307405 on March 23, 2026: 73.2–74.8% efficacy in ages 5 and older. Regulatory submissions planned for 2026. No Lyme vaccine has been available in the U.S. since 2002.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Mpox Clade I Has Spread Beyond Africa and Is Now Circulating Locally in Europe. The CDC Expects More U.S. Cases — and the Vaccine Gap Is Getting Harder to Ignore.

More than 20 clade I mpox cases have been confirmed in the U.S. as of June 2026. The CDC now expects additional cases as local clade Ib transmission has been detected in Europe among men who have sex with men with no travel history to Africa. JYNNEOS vaccine uptake lags…

Medical Daily

Whooping Cough Is Still Killing Americans in 2026, and California, Washington, Ohio, and Florida Are Leading a Surge That Is Far from Over

Whooping cough hit its highest U.S. case count in more than a decade in 2024 and 2025, killing infants and adults. In 2026, California leads the nation with nearly 700 cases. Falling vaccination rates, waning immunity, and public health cuts are driving the surge. Here is the full picture.

Medical Daily

Who is eligible for the MenB vaccine? New one-off programme to protect vulnerable to be rolled out

MenB is a serious bacterial infection caused by Neisseria meningitis group B

The Independent UK

UK to offer free Meningitis B vaccine to 1 million young people after deadly outbreaks

A major NHS programme will offer the meningitis B vaccine to around one million young people across the UK, including Year 13 students and those under 25 starting university. This initiative aims to protect vulnerable individuals entering environments where the disease spreads easily, following recent life-claiming outbreaks.

The Times of India

Meningitis B vaccine: Who is eligible – and when will it be offered?

IN FULL

The Independent UK

UK school leavers and new students to be offered meningitis B vaccine

One-off programme to begin in July after recent MenB outbreaks in Kent, Dorset and Berkshire killed three people

The Guardian - UK

One million young people to be offered meningitis B vaccine on NHS after deadly outbreaks

The one-off programme is set to be offered to young people this autumn

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

Century-old tuberculosis vaccine could help treat diabetes, trials hint. How?

Repeated doses of a tuberculosis vaccine lowered insulin needs in patients with two forms of diabetes, new trial data show. But more research is needed to prove the benefit.

Evening Standard

Two children die from measles as more cases confirmed in London this month

The UKHSA says measles continues to circulate in many parts of the country with 736 cases recorded this year

The Independent UK

OB-GYN group breaks with CDC and issues own vaccine recommendations

The biggest difference involves the COVID-19 vaccine

The Independent UK

Motorcycle taxi drivers in Congo rally for Ebola awareness as attacks hinder response

Dozens of motorcycle taxi drivers have joined an Ebola awareness caravan in eastern Congo

Get all your
news in one place.

100's of premium titles.
One news app.

Latin Times

CDC Admits It Deliberately Delayed COVID-19 Vaccine Study Showing Reduced Hospitalizations

The Centers for Disease Control and Prevention is facing growing scrutiny after officials acknowledged the agency intentionally delayed the release of a study showing the effectiveness of the latest COVID-19 booster, a decision now fueling debate over transparency and public health messaging.

The Guardian - UK

Cattle in England to get tuberculosis vaccine from 2030 as badger cull to end

Targeted vaccination and improved testing planned as part of drive to eradicate disease by 2038

LiveScience

3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready?

The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that.

The Independent UK

Bulletin world briefing: Black bear chaos in Japan and major vaccine breakthrough

Here are five of the biggest stories from around the world today

The Independent UK

What is Lassa fever and is there a vaccine for it?

IN FULL

The Independent UK

Lassa fever vaccine for deadly virus within reach after ‘promising’ trial results

About 300,000 Lassa fever infections occur every year killing 5,000 people a year, but a vaccine could save lives

The Conversation

World’s first AI-designed vaccine explained

Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine’s key component was designed entirely by AI and has now been tested in people for the first time.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

239 stories

the University of Cambridge

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.